SAN DIEGO (Reuters) – Nearly 40 percent of lymphoma patients treated with a single infusion of Gilead Sciences Inc’s Yescarta were still responding to the cell therapy after at least two years of follow-up, the company said on Sunday. FILE PHOTO: A Gilead Sciences, Inc. office is shown in Foster City, California, U.S. May 1,… Read More »
In 2010, the debilitating effects of multiple sclerosis forced Sam Harrell to retire from his position as Head Football Coach at Ennis High School. But after receiving 3 courses of stem cell therapy at the Stem Cell Institute in Panama, Sam is returing to the gridiron once again. Brownwood Lion Head Coach, Bob Shipley… Read More »
As a reader of this website, you are probably well versed in the dangers associated with using cell phones. There is evidence that their radiation alters brain activity. Plus, phones—or any other device with a screen like a laptop or tablet—affect the quality of your sleep when you use them close to bedtime. And now… Read More »